HDL as a Biomarker, Potential Therapeutic Target, and Therapy

  • Mohamad Navab
    Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California;
  • G.M. Anantharamaiah
    Atherosclerosis Research Unit, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Srinivasa T. Reddy
    Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California;
  • Brian J. Van Lenten
    Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California;
  • Alan M. Fogelman
    Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California;

収録刊行物

  • Diabetes

    Diabetes 58 (12), 2711-2717, 2009-12-01

    American Diabetes Association

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ